Orgasmic Dysfunction After Robot-assisted Versus Open Radical Prostatectomy

Capogrosso, Paolo; Ventimiglia, Eugenio; Serino, Alessandro; Stabile, Armando; Boeri, Luca; Gandaglia, Giorgio; Dehò, Federico; Briganti, Alberto; Montorsi, Francesco; Salonia, Andrea

doi:10.1016/j.eururo.2015.10.046

Cited by 39 publications

(42 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The exact prevalence of climacturia in patients who undergo RP is unknown, given the huge variability in reported rates, ranging between 20% and 93% (Table 1) [232425262728293031]. In 1996, Koeman et al [24] first assessed orgasmic problems in a small series of patients treated with RP and reported that 9 out of 14 patients experienced involuntary loss of urine at orgasm.…”

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

“…Similar results supporting the possibility of recovering from climacturia were also reported by Blaivas [32] . More recently, in a series of 354 RARP patients, climacturia was reported by 31.1% of patients at a 1-year postoperative follow-up assessment, with no significant difference compared to an age-matched ORP group [31]. Overall, fewer than 1% of patients complaining of climacturia had recovered from their complaint by 12 months after surgery, and 84% of them still had not recovered from climacturia after 60 months.…”

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

“…Overall, fewer than 1% of patients complaining of climacturia had recovered from their complaint by 12 months after surgery, and 84% of them still had not recovered from climacturia after 60 months. However, after adjusting the analyses for the type of surgery, the authors observed that patients treated with RARP showed significantly higher rates of recovery from climacturia than the ORP group, with a rate of recovery of 8% and 5% after RARP and ORP at a 24-month assessment, respectively; likewise, the rates of recovery were 48% and 13% after the 2 types of surgery after more than 80 months, respectively [31]. …”

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

“…Conversely, Nilsson et al [28] explored orgasm-associated incontinence in a consecutive series of 691 sexually active RP patients, of whom 268 reported climacturia despite recovering full UC in 86% of cases. Of note, all these studies investigated the prevalence of climacturia after surgery in a non-time-dependent fashion; in contrast, when looking at potential predictors of recovery from climacturia over time, robotic surgery emerged as the only independent predictor of recovery, after adjusting for age at surgery, body mass index, and nerve-sparing status, as well as UC and EF recovery rates [31]. …”

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

“…Previous data have reported rates of up to 19% of patients complaining of PO after RP (Table 2) [2024272830313334]. More recently, Frey et al [30] reported that 23 out of 256 patients treated with RP suffered from PO over the postoperative period.…”

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

See 4 more Smart Citations

Orgasmic Dysfunction after Radical Prostatectomy

Capogrosso

Ventimiglia

Cazzaniga

et al. 2017

World J Mens Health

Self Cite

View full text Add to dashboard Cite

In addition to urinary incontinence and erectile dysfunction, several other impairments of sexual function potentially occurring after radical prostatectomy (RP) have been described; as a whole, these less frequently assessed disorders are referred to as neglected side effects. In particular, orgasmic dysfunctions (ODs) have been reported in a non-negligible number of cases, with detrimental impacts on patients' overall sexual life. This review aimed to comprehensively discuss the prevalence and physiopathology of post-RP ODs, as well as potential treatment options. Orgasm-associated incontinence (climacturia) has been reported to occur in between 20% and 93% of patients after RP. Similarly, up to 19% of patients complain of postoperative orgasm-associated pain, mainly referred pain at the level of the penis. Moreover, impairment in the sensation of orgasm or even complete anorgasmia has been reported in 33% to 77% of patients after surgery. Clinical and surgical factors including age, the use of a nerve-sparing technique, and robotic surgery have been variably associated with the risk of ODs after RP, although robust and reliable data allowing for a proper estimation of the risk of postoperative orgasmic function impairment are still lacking. Likewise, little evidence regarding the management of postoperative ODs is currently available. In general, physicians should be aware of the prevalence of ODs after RP, in order to properly counsel all patients both preoperatively and immediately post-RP about the potential occurrence of bothersome and distressful changes in their overall sexual function.

show abstract

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

Section: Prevalence Of Orgasmic Dysfunctions After Radical Prostatectomymentioning

confidence: 99%

See 3 more Smart Citations

Orgasmic Dysfunction after Radical Prostatectomy

Capogrosso

Ventimiglia

Cazzaniga

et al. 2017

World J Mens Health

Self Cite

View full text Add to dashboard Cite

show abstract

How does lower urinary tract dysfunction (LUTD) affect sexual function in men and women? ICI‐RS 2015—Part 2

Apostolidis

Rantell

Anding

et al. 2017

Neurourology and Urodynamics

View full text Add to dashboard Cite

Neurovascular and hormonal factors, but also indirect effects may link LUTD to SD in both sexes, but the evidence is not robust and the mechanisms unclear. There is a need for defining the terminology and standardizing outcomes assessed in clinical trials. The multifactorial nature of SF in both sexes makes trial design challenging and "real world" studies may prove more beneficial for patients' outcomes and clinicians' understanding.

show abstract